Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

The increase of antimicrobial resistance in ICUs is mainly due to the spread of HiRCs and is
exemplified with the ESKAPE Gram-negative microorganisms. The COVID-19 pandemic …

Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …

Data on microbiological profiles in odontogenic infections are scarce. This study aimed to
analyze the spectrum of pathogens and antimicrobial resistance in clinical isolates from …

Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …

Vancomycin-resistant Enterococcus faecium (VREF) and methicillin-resistant
Staphylococcus aureus (MRSA) are associated with significant health burden. We …

Phenotypic heterogeneity is crucial to bacterial survival and could provide insights into the
mechanism of action (MOA) of antibiotics, especially those with polypharmacological …

Multidrug-resistant Acinetobacter baumannii (MDRAB) is a pathogen recognized as
antimicrobial-resistant bacteria involved in healthcare-associated infections. Resistance to …

Carbapenem-resistant Acinetobacter baumannii (CRAb) is an important pathogen causing
serious nosocomial infections. We describe an outbreak of CRAb in an intensive care unit in …

Background/Objectives: Carbapenem resistance poses a significant threat to public health
by undermining the efficacy of one of the last lines of antibiotic defense. Addressing this …